U.S. drug prices at manufacturer level compared to other countries by multiplier 2020
retail level.
This statistic shows selected drugs' net prices in the United States compared to gross prices in Australia, Canada, and France at the manufacturer level as of 2020.
As of 2020, the estimated U.S. net prices for a selected group of 20 brand-name, single-source prescription drugs were over 4 times higher than gross prices paid at the manufacturer level in Australia and France. U.S. prices were also 2.7 times higher than gross prices paid in Canada (Ontario). This is similar to the price comparison at the